ACADIA Pharmaceuticals Inc. news

   Watch this stock
Showing stories 1 - 10 of about 73   

Articles published

ACAD 23.58 -0.23 (-0.97%)
price chart
Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio ...
Investor-Edge has initiated coverage on the following equities: Aegerion Pharmaceuticals Inc. AEGR, +5.75% ACADIA Pharmaceuticals Inc. ACAD, -0.59% Inovio Pharmaceuticals Inc. (nyse mkt:INO), Curis Inc. CRIS, -0.94% and Seattle Genetics Inc. SGEN, ...
Related articles »  
What's Leading Biotechs Higher? � ACADIA Pharmaceuticals Inc. (ACAD ...
Biotech stocks continue to make noteworthy gains following U.S. stocks higher on M&A activity and a report showing an increase in optimism among U.S.
ACADIA Pharmaceuticals Reports Second Quarter 2014 Financial Results
SAN DIEGO, Aug 05, 2014 (BUSINESS WIRE) -- ACADIA Pharmaceuticals Inc. ACAD, +4.42% a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and ...
ACADIA Pharmaceuticals' (ACAD) CEO Uli Hacksell on Q2 2014 Results ...  Seeking Alpha (registration)
Related articles »  
Worth Watching Stocks: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CEO Uli Hacksell unloaded 15,000 shares of the company's stock on the open market in a transaction dated Friday, August 15th.
How ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Rally Leaves Behind ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical firm aimed on the development and commercialization of innovative medicines that address unmet medical requirements in neurological and related central nervous system disorders, on ...
ACADIA Pharmaceuticals Inc.: ACADIA Pharmaceuticals to Announce Second ...
29, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system ...
Related articles »  
Today's Hot List : Gilead Sciences Inc. (NASDAQ:GILD), ACADIA ...
On AUG 5, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced its unaudited financial results for the second quarter ended June 30, 2014.
Related articles »  
ACADIA Pharmaceuticals CEO Uli Hacksell Unloads 15000 Shares (ACAD)
The company reported ($0.22) earnings per share for the quarter, missing the analysts' consensus estimate of ($0.17) by $0.05.
ACADIA Pharmaceuticals CEO Uli Hacksell Sells 15000 Shares (ACAD)  Watch List News (press release)
Insider Selling: Uli Hacksell Sells 15000 Shares of ACADIA Pharmaceuticals ...  Mideast Time
Related articles »  
Stocks Trending Alert - ACADIA Pharmaceuticals, (NASDAQ:ACAD),NOW Inc ...
ACADIA Pharmaceuticals, (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, ...
Mid Cap Stocks going down: ACADIA Pharmaceuticals Inc. (ACAD), AerCap ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, ...
Related articles »